Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention

Cardiovasc DiabetolPublished Retrospective cohort study

Main finding · MACCEResult — go to the resultHazard ratio 1.53 95% CI 1.16–2.01

Authors' conclusion

The TyG index is independently associated with MACCE, suggesting that the TyG index may serve as a valid indicator for predicting poor prognosis in ACS patients with prior CABG undergoing PCI.

Study context

Population
Acute coronary syndrome (ACS) patients with prior coronary artery bypass grafting (CABG) undergoing percutaneous coronary intervention (PCI)
Participants
1,158 patients
Exposure
High vs low triglyceride-glucose (TyG) index
Outcome
MACCE: composite of all-cause death, nonfatal MI, nonfatal stroke and unplanned repeat revascularization
Follow-up
median 42-month follow-up

Main finding

MACCE

Hazard ratio

1.53

95% CI 1.16–2.01

P = 0.003

By group

High TyG indexvs Low TyG index
HR 1.53 (95% CI 1.16–2.01); P = 0.003

As reported in the abstract

Patients with ≥1 endpoint event, overall
350 (30.2%)

Observational data: associations, not effects.

Further findings

MACE

P = 0.003

Nonfatal stroke

P = 0.022

Unplanned repeat revascularization

P < 0.001

Shape of TyG index–major adverse cardiovascular and cerebrovascular events (MACCE) relationship (restricted cubic spline)

Linear relationship
p for non-linear = 0.595, p for overall = 0.005

Prediction of MACCE (AUC)

AUC baseline risk model
0.618
AUC baseline risk model + TyG index groups
0.636
Improvement in accuracy
p for comparison = 0.042

Original publication

Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention. Cardiovasc Diabetol. Published 27 October 2023. doi:10.1186/s12933-023-02029-6

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.